Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Suppose you are tasked with evaluating the merits of a new prostate cancer treatment regimen relative to the current treatment regimen on behalf of a
Suppose you are tasked with evaluating the merits of a new prostate cancer treatment regimen relative to the current treatment regimen on behalf of a US health insurance company. Given the information below, answer the questions that follow.
| Cost | Result | |
| Current Treatment | $50,000 | 4 life-years gained |
| New Treatment | $75,000 | 5 life-years gained |
- Now assume that the new treatment has far fewer side-effects than the current treatment. As a result, the average QALY per life-year gained is 0.8 for the new treatment, compared to 0.5 for the current treatment. Which treatment is more cost-effective in terms of quality-adjusted life-years gained? Why? Show your calculations.
- Should the new treatment be considered acceptably cost-effective, given commonly used QALY thresholds in the US? Why or why not?
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access with AI-Powered Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started